Neuronasal-Team

Thomas I. Bradshaw, BA, MBA – CEO


President /CEO
  • Contract drug development company serving most of the major biotech companies in US.
  • Organized the purchase of the company in 2003 including arranging financing with private equity. Led turnaround and profitable growth of company.  Sold to SV Life Sciences and Bain in 2007.
  • Many lessons learned from clients’ decisions.

Since then:

  • Buckeye Pharmaceuticals – now in clinical development for topical diseases –  co-founder and currently chairman
  • Great Lakes Pharmaceuticals, former chairman and co-founder – just completed pivotal clinical trials for catheter lock (IP from MD Anderson, Case Western)
  • ​Devirex Pharmaceuticals – herpes prevention drug on the market in the EU – co-founder
  • Zin Medical Europe  – remote patient monitoring (IP from NASA prime contractor and Cleveland Clinic)​

Michael Kaufman,

Vice President, Business Development & Commercialization.

Douglas A. Greene MD,

 Head of Research 

Joe Hulihan MD,

Chief Medical Officer